Back to Search
Start Over
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
- Source :
- Diabetes and Metabolism, Diabetes and Metabolism, Elsevier Masson, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩, Diabetes & Metabolism, Diabetes & Metabolism, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩, Endocrinology, Diabetes & Metabolism, Endocrinology, Diabetes & Metabolism, Wiley, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
- Publication Year :
- 2021
- Publisher :
- HAL CCSD, 2021.
-
Abstract
- International audience; Type 2 diabetes mellitus (T2DM) is a frequent comorbidity in patients with cirrhosis that is projected to rise in prevalence due to the worldwide burden of obesity, insulin-resistance and non-alcoholic fatty liver disease. The management of T2DM in patients with cirrhosis is complex given the requirement for accurate adaptation according to the level of liver function impairment, with lack of summary of the little evidence available in the literature. Here, we summarise the data available with respect to the epidemiology and the impact of T2DM in patients with cirrhosis, as well as those on the management of T2DM in these patients. We provide guidance for the diagnosis of T2DM and the monitoring of glycaemic control in patients with cirrhosis, and for the management of nutrition and pharmacological treatments in relation to the level of liver dysfunction.
- Subjects :
- Liver Cirrhosis
medicine.medical_specialty
Cirrhosis
endocrine system diseases
Monitoring
Epidemiology
Endocrinology, Diabetes and Metabolism
[SDV]Life Sciences [q-bio]
Disease
03 medical and health sciences
0302 clinical medicine
Endocrinology
Non-alcoholic Fatty Liver Disease
Diabetes mellitus
Diagnosis
Type 2 diabetes mellitus
Internal Medicine
medicine
Humans
Intensive care medicine
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
0303 health sciences
business.industry
Fatty liver
Type 2 Diabetes Mellitus
nutritional and metabolic diseases
General Medicine
medicine.disease
Comorbidity
Fibrosis
3. Good health
Diabetes Mellitus, Type 2
030220 oncology & carcinogenesis
Liver function
Insulin Resistance
business
Pharmacological treatment
Subjects
Details
- Language :
- English
- ISSN :
- 12623636, 18781780, and 23989238
- Database :
- OpenAIRE
- Journal :
- Diabetes and Metabolism, Diabetes and Metabolism, Elsevier Masson, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩, Diabetes & Metabolism, Diabetes & Metabolism, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩, Endocrinology, Diabetes & Metabolism, Endocrinology, Diabetes & Metabolism, Wiley, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
- Accession number :
- edsair.doi.dedup.....64e43e676e675de17412e9279a3b8a75